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ABSTRACT 
This study investigated the effect of the 
biochemical and biophysical properties of the 
plasma membrane as well as membrane 
morphology on the susceptibility of human red 
blood cells to the cholesterol-dependent cytolysin 
pneumolysin, a key virulence factor of 
Streptococcus pneumoniae, using single cell 
studies. We show a correlation between the 
physical properties of the membrane (bending 
rigidity, surface and dipole electrostatic potentials) 
and the susceptibility of red blood cells to 
pneumolysin-induced haemolysis. We demonstrate 
that biochemical modifications of the membrane 
induced by oxidative stress, lipid scrambling and 
artificial cell aging modulate the cell response to 
the toxin. We provide evidence that the diversity 
of response to pneumolysin in diabetic red blood 
cells correlates with levels of glycated 
haemoglobin (Hba1c) and that the mechanical 
properties of the red blood cell plasma membrane 
are altered in diabetes. Finally, we show that 
diabetic red blood cells are more resistant to 
pneumolysin and the related toxin perfringolysin 
O relative to healthy red blood cells. Taken 
together, these studies indicate that the diversity of 
cell response to pneumolysin within a population 
of human red blood cells is influenced by the 
biophysical and biochemical status of the plasma 
membrane and the chemical and/or oxidative 
stress prehistory of the cell.  
 
The interaction of toxins with their target 
cells is generally characterised by a dose-response 
curve that is sigmoidal in shape (1). This shape is 
taken to reflect the differing susceptibilities of 
individual cells within the population. The fact 
that red blood cells (RBCs), with their less 
developed glycocalyx compared to other cell types 
(2), exhibit such a response is evidence that the 
initial interaction between the toxin and the 
plasma membrane is subject to, and probably the 
main determinant of, such variability. Therefore, it 
is important to understand the biochemical and 
biophysical factors affecting toxin-membrane 
interactions and the resulting variability of 
susceptibility within the same cell population.   
Individual RBCs within a population 
differ significantly (3) with respect to their shape, 
volume and surface area. Some of these changes 
are related to cell age, due to the variety of 
 http://www.jbc.org/cgi/doi/10.1074/jbc.M115.691899The latest version is at 
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mechanical and chemical stresses that a RBC 
undergoes in its life span of approximately 120 
days (4,5), and others can be associated with 
diseases, such as diabetes and with acute 
conditions, such as sepsis, amongst many others 
(6) and thus, are likely to be present in the 
membranes of many other cell types.  
Previous work on bulk cell preparations 
revealed that in addition to its normal discocytic 
shape, the RBC at rest can assume a variety of 
other distinct shapes, such as echinocytes and 
acanthocytes, characterised by exterior 
projections, and stomatocytes with cup-shaped 
invaginations (7). Many of these unusual shapes 
appear in normal blood at a frequency of about 1 
%. However, during blood bank storage and in 
many inflammatory, degenerative and 
microvascular disorders the frequency of RBCs 
with altered morphology increases (8-12). For 
example, an increase of 13% in echinocytes was 
observed in patients suffering from chronic 
hepatitis (13) and in neuroacanthocytosis 
syndromes, a group of rare neurodegenerative 
diseases that mainly affect children and young 
adults, acanthocytes appear with a frequency of 
12% to 45% (14).  
High heterogeneity in the size of 
circulating erythrocytes can also have a dramatic 
impact on the health and function of the entire cell 
population (4,5,15). Recent studies indicate that 
the RBC distribution width (RDW), a measure of 
the size variation of circulating erythrocytes with a 
normal reference range of 11–15% (16), is a 
strong predictor of cardiovascular and thrombotic 
disorders (15,17), with a positive correlation 
between increased RDW and peripheral artery 
diseases (18).  
Aging RBCs are characterised by a 
decrease in size, usually explained in terms of a 
decrease in cell area due to loss of lipids (19), and 
by surface modifications that include external 
exposure of membrane phosphatidylserine (PS) 
and decreased levels of sialic acid (20,21). 
Exposure of PS on the outer leaflet of the 
membrane marks the cell for recognition and 
phagocytosis by macrophages.  
A number of studies have shown that 
aging of RBCs influences their sensitivity to 
bacterial toxins. For example, human RBCs during 
blood bank storage become more susceptible to 
sublytic concentrations of phospholipase C from 
either Bacillus cereus or Clostridium perfringens 
(12,22). Age-development changes in 
susceptibility of RBCs to the pore-forming toxin 
(PFT) perfringolysin O (PFO) from C. 
perfringens, a member of the cholesterol-
dependent cytolysin (CDC) family of PFTs, have 
been demonstrated in mice, with RBCs of old 
mice being more susceptible to the toxin than 
those of young mice (23). Old RBC populations 
and peroxyl-oxidized RBCs also showed more 
susceptibility to hemolysis by the PFT stycholysin 
II from the sea anemone Stichodactyla helianthus 
compared to young cell populations (21).  In 
contrast, old RBCs from rabbits are less 
susceptible to Staphylococcus aureus α-toxin 
relative to young RBCs (24-26). This is due to 
degradation of the membrane protein Band 3 in 
older RBCs (27), a binding site for staphylococcal 
α-toxin. The chemistry of lipid rafts (e.g. 
cholesterol content) is also known to change with 
age and such changes could alter the susceptibility 
of the host cell to toxin action (28). 
Like PFO, pneumolysin (PLY) is also a 
member of the CDC family of PFTs (29). PLY is a 
key virulence factor of the bacterial pathogen 
Streptococcus pneumoniae (30,31) and plays a 
role in a range of human diseases, such as 
pneumonia, sepsis and meningitis (32). Disease is 
especially common in children, the elderly and in 
immunocompromised and diabetic individuals 
(30).  
PLY is released from the bacterium as an 
inactive, water-soluble monomer (53 kDa). 
Monomeric PLY is an elongated molecule 
organised into four domains (33,34). Three short 
hydrophobic loops and the highly conserved 
tryptophan-rich loop at the base of domain 4 
anchor the toxin to the membrane (35,36), with a 
highly conserved threonine-leucine pair in loop 1 
critical for cholesterol binding (37), the receptor 
for most CDCs (38,39). Two putative 
carbohydrate-binding sites have also been 
identified in PLY: one near the conserved 
tryptophan-rich loop in domain 4 and the other at 
the domain 3-domain 4 interface (33,40).  
Pore-formation by PLY is a multistep 
process. Upon binding to the membrane, PLY 
monomers interact with each other and form an 
oligomeric pre-pore complex on the membrane 
surface that contain 30-50 monomers (41,42). Pre-
pore to pore transition is associated with 
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significant conformational changes in the complex 
and consequent membrane insertion of the 
oligomer that leads to the formation of large pores 
of 32-43 nm in diameter and ultimately, to cell 
lysis (43-45).  
A wide range of host cells are susceptible 
to the action of PLY, and although erythrocytes 
are not the primary target for the toxin in vivo, 
they are the cell type most commonly used to 
measure activity towards host cells (46).  
To date, the relationship between the 
plasma membrane properties and the variability in 
cell response to toxin within a population has 
largely been unexplored. Therefore, the aim of this 
study was to investigate the effect of the 
biochemical (oxidative stress, lipid scrambling and 
artificial cell aging) and biophysical properties 
(bending rigidity, surface and dipole electrostatic 
potentials) of the plasma membrane and the effect 
of membrane morphology on the susceptibility of 
RBCs to PLY (47), using single cell studies. 
Finally, we sought to establish whether the 
response to PLY in populations of RBCs derived 
from diabetic subjects correlates with levels of 
glycated haemoglobin (Hba1c), which is elevated 
in people with diabetes and is likely to alter 
membrane physical characteristics via glucose 
induced biochemical modifications. 
 
EXPERIMENTAL PROCEDURES 
MaterialsChemicals were purchased 
from Sigma-Aldrich, UK unless otherwise stated. 
Recombinant wild-type pneumolysin with N-
terminal 6x His tag (PLY), recombinant wild-type 
pneumolysin with N-terminal 6x His and eGFP 
tags (eGFP-PLY) and perfringolysin O (PFO) 
were generated, expressed and purified as 
described in (48-50); eGFP-PLY is monomeric in 
solution as judged by size exclusion 
chromatography and analytical ultracentrifugation 
experiments and has a specific activity similar to 
unlabelled PLY at equivalent molarity (data not 
shown). Recombinant plasmid pET-33b(+) 
containing the non-lytic and aggregation negative 
variant of eGFP-PLY, termed eGFP-6PLYL363A, 
was generated as described in (49).  
Expression and purification of eGFP-
6PLYL363AFor expression of eGFP-6PLYL363A, 
recombinant plasmid was transferred into E. coli 
Rosetta 2 (DE3) cells (Merck, Darmstadt, 
Germany) and expression of eGFP-6PLYL363A 
was induced using the autoinduction system as 
described in (51). 
Time course of hemolysis induced by PLY 
within a population of human RBCsFresh whole 
blood from healthy (n = 17) and diabetic 
individuals (n = 36) was collected by 
venepuncture from the University of Exeter 
Medical School, NIHR Exeter Clinical Research 
Facility, Diabetes and Vascular Medicine Centre, 
Exeter, UK into neutral tubes and 1 mL whole 
blood was immediately transferred into 20 mL 
DPBS buffer with pH 7.0-7.2 (Invitrogen) 
supplemented with 1 mg/mL bovine serum 
albumin (BSA) (DPBS/BSA). RBCs were washed 
three times in DPBS/BSA, resuspended in 
DPBS/BSA at a concentration of 3 x 10
7
 cells/mL 
and cells (90 µL) were incubated with PLY at a 
final concentration of 118 ng/mL (2.2 nM) for 30 
minutes at room temperature, similar to the dose 
(1 nM) frequently used in the literature under 
comparable experimental conditions (40,52). The 
time course of hemolysis was monitored by phase 
contrast microscopy (Zeiss Axiophot upright 
microscope equipped with a Plan Neofluar 20x / 
0.5 Air objective). Images were captured every 2 
minutes for 30 minutes using a Spot Pursuit™ 1.4 
MP Monochrome CCD camera (Visitron 
Systems). The number of lysed cells was counted 
and the percentage of lysed cells was calculated 
for each time point. 
Analysis of binding of recombinant eGFP-
PLY and eGFP-6PLYL363A to human RBCs by 
microscopyTo investigate whether the variation 
of cell response to PLY within a population of 
RBCs correlates to the amount of toxin bound to 
the membrane, RBCs (Innovative Research) were 
diluted to 6 x 10
7
 cells/mL in DPBS/BSA and cells 
(90 µL) were incubated with eGFP-PLY at a final 
concentration of 0.67 µg/mL to allow optimal 
detection of eGFP fluorescence by microscopy.  
To investigate whether increased 
sensitivity of stomatocytes to PLY correlates to 
the amount of toxin bound to the membrane, fresh 
blood was collected from healthy volunteers using 
a pin-prick lancet and immediately suspended in 
DPBS/BSA (approximately 3 x 10
7
 cells/mL). 
Cells (90 µL) were incubated with eGFP-
6PLYL363A at a final concentration of 1.12 
µg/mL. 
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Cells were imaged at room temperature 
using an Olympus IX81 microscope (Olympus 
Optical, Hamburg, Germany) equipped with a 
PlanApo 100x / 1.40 oil objective and eGFP filter 
sets equipped with a 470/40 ET Bandpass, 
Beamsplitter T 495 LPXR and a 525/50 ET 
Bandpass filter (Chroma Technology Corp. 
Olching, Germany).  
Each image had its background intensity 
subtracted and the GFP intensities of cells were 
measured 2 minutes after exposure to toxin using 
ImageJ software (53).  
Simulated oxidative stress and 
agingFresh whole blood from healthy individuals 
was collected by venepuncture from the University 
of Exeter Medical School, NIHR Exeter Clinical 
Research Facility, Diabetes and Vascular 
Medicine Centre, Exeter, UK into neutral tubes 
and 1 mL whole blood was immediately 
transferred into DPBS/BSA. Cells were washed 
three times with DPBS/BSA and resuspended in 
DPBS/BSA to 3 x 10
7
 cells/mL.  
To simulate oxidative stress we used two 
different oxidants, the water-soluble hydrogen 
peroxide (H2O2) and the membrane-soluble 
cumene hydroperoxide (cumOOH). Solutions 
were prepared in DPBS/BSA immediately before 
each experiment to minimise peroxide 
degradation. To disperse cumOOH at the 
necessary concentration into DPBS/BSA, the 
mixture was vigorously vortexed for a few 
minutes.  
We used two different approaches to 
simulate cell aging. The first one relies on cell 
treatment with the steroid hormone 
dehydroepiandrosterone (DHEA). In DHEA 
treated cells, inhibition of glucose-6-phosphate 
dehydrogenase (G6PD) activity results in 
decreased levels of NADPH, an essential cofactor 
that helps maintain glutathione (GSH) in its 
reduced, antioxidant form (54). Thus, decreased 
levels of GSH weaken the cell’s antioxidant 
defence system. The second approach used 
calcium ionophore A23187. It has been 
demonstrated that treatment of RBCs with calcium 
ionophore A23187 causes internalisation of Ca
2+
 
leading to fast phosphatidylserine (PS) 
translocation from the inner monolayer to the 
outer monolayer of the plasma membrane, as well 
as cell shrinkage and membrane blebbing, which 
are typical signs of apoptosis (55-58).  
Human RBCs from healthy individuals 
were diluted to 3 x 10
7
 cells/mL in DPBS/BSA 
and cells (1 mL) were incubated with H2O2 (100 
M), cumOOH (100 M), DHEA (35 µM), 
calcium ionophore A23187 (20 µM, in the 
presence of 0.9 mM calcium chloride) or 
DPBS/BSA (as control) for 2 hours at 37 °C. The 
solvent concentration in DHEA and calcium 
ionophore A23187-treated samples was kept 
below 1% (v/v). After incubation, cells were 
washed three times in DPBS/BSA and 
resuspended in 1 mL DPBS/BSA. Cells (90 µL) 
were exposed to PLY at a final concentration of 
118 ng/mL or perfringolysin O at a final 
concentration of 72 ng/mL and the time course of 
hemolysis was monitored by phase contrast 
microscopy (Zeiss Axiophot upright microscope 
equipped with a Plan Neofluar 20x / 0.5 Air 
objective). Images were captured every 2 minutes 
for 30 minutes using a Spot Pursuit™ 1.4 MP 
Monochrome CCD camera (Visitron Systems). 
The number of lysed cells was counted and the 
percentage of lysed cells was calculated for each 
time point.  
Flow cytometry analysis of calcium 
ionophore A23187-treated RBCs exposed to 
eGFP-6PLYL363AHuman RBCs from healthy 
individuals were diluted to 5 x 10
6
 cells/mL and 
cells (1 mL) were incubated with calcium 
ionophore A23187 (20 µM, in the presence of 0.9 
mM calcium chloride) or ethanol aqueous solution 
(as control) for 1 hour at 37 °C; the solvent 
(ethanol) concentration in both samples was 0.1 % 
(v/v). After incubation, cells were washed three 
times in DPBS/BSA and resuspended in annexin 
V binding buffer (10 mM HEPES, 140 mM 
sodium chloride and 2.5 mM calcium chloride, pH 
7.4, BD Biosciences) at a concentration of 1 x 10
6
 
cells/mL. Cells (100 µL) were labelled with 5 µL 
annexin V Alexa Fluor® 594 Conjugate 
(Molecular Probes) for 15 minutes at room 
temperature followed by incubation with eGFP-
6PLYL363A at a final concentration of 1.67 µg/mL 
for 2 minutes at room temperature. After the 
incubation period, 400 µL of ice-cold annexin V 
binding buffer was added to each sample and cells 
were analyzed by flow cytometry using 488 nm 
and 633 nm excitation on a BD FACSARIA II 
Cytometer with 530/30 and 660/20 bandpass 
filters. The number of events noted for each 
sample was 10,000. 
 at The U
niversity of Birm
ingham
 on D
ecem
ber 2, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Red Blood Cell Properties and Susceptibility to Pneumolysin 
5 
 
Ratiometric measurement of the 
membrane dipole potentialIn separate 
experiments, the membrane dipole potential was 
measured before exposing RBCs (100 µL at 3 x 
10
7
 cells/mL in DPBS/BSA) to PLY (5.9 ng/mL) 
in a μ–Slide I0.4 Luer poly-L-lysine imaging 
chamber (Ibidi). The membrane dipole potential 
was measured using ratiometric fluorescence 
imaging of Di-8-ANEPPS labelled RBC 
membranes. 5 µL of 1 mg/mL Di-8-ANEPPS in 
ethanol was added to 1 mL RBC suspension and 
cells were incubated at 37 °C for 1 hour. 
Subsequently, cells were washed three times in 
DPBS/BSA to remove excess dye and resuspended 
in 1 mL DPBS/BSA. Ratiometric measurement of 
the membrane dipole potential was performed on 
an Olympus IX50 inverted microscope using a 63x 
oil immersion objective. Excitation light with a 
selectable wavelength was provided by a Till 
Photonics Polychrome V monochromator and the 
images were recorded using a high-sensitivity 
CCD camera (AVT Stingray F-145B) attached to 
the microscope in conjunction with a 650/50 nm 
emission filter (Thorlabs). Two consecutive 
images using excitation at 420 nm and 520 nm 
(each with an exposure time of 500 ms, with 5 ms 
between them) were recorded. Each image (n = 
24) had its background intensity subtracted before 
the 420 nm excitation image was divided by the 
520 nm excitation image to produce a matrix of 
the ratiometric intensity, R = I420/I520 using ImageJ 
software (53).  The value of the membrane dipole 
potential d (in mV), averaged over the whole cell, 
can be found from the following calibration 
dependence (59): 𝜓𝑑 =
𝑅+0.3
0.0043
 
Measurement of the membrane surface 
potentialSimilarly to the membrane dipole 
potential, the membrane surface electrostatic 
potential of RBCs (100 µL at 3 x 10
7
 cells/mL in 
DPBS/BSA) was evaluated before exposing the 
cells to PLY (5.9 ng/mL) in a μ–Slide I0.4 Luer 
Poly-L-Lysine imaging chamber (Ibidi). The 
membrane surface potential was measured using 
fluorescence intensity measurements of 
fluorescein-phosphatidylethanolamine (FPE; 
Molecular Probes) incorporated in the RBC 
membrane. The quantum yield of this probe is 
sensitive to the charge density of its immediate 
environment. Therefore, changes in the membrane 
surface electrostatic potential are manifested by 
changes in the fluorescence intensity recorded 
(60,61). A decrease in the net negative charge of 
the surface results in deprotonation of fluorescein 
and a consequent increase in its fluorescence 
intensity.  
Human RBCs were labelled with FPE 
following a protocol adapted from (62). In brief, 
12.5 µg FPE dissolved in 2.5 µL ethanol was 
added to 3 x 10
7
 RBCs in 1 mL DPBS/BSA and 
cells were incubated at 37 °C for 1 hour. 
Subsequently, cells were washed three times in 
DPBS/BSA to remove excess dye and resuspended 
in 1 mL DPBS/BSA. Fluorescence intensity 
measurements of FPE-labelled cells (n = 108) 
were performed using an Olympus IX81 
microscope (Olympus Optical, Hamburg, 
Germany) equipped with a UPlanFL N 40x / 1.3 
oil objective and eGFP filter sets equipped with a 
470/40 ET Bandpass, Beamsplitter T 495 LPXR 
and a 525/50 ET Bandpass filter (Chroma 
Technology Corp. Olching, Germany). 
Measurement of the membrane bending 
elasticity using thermal fluctuation 
spectroscopyHuman RBCs were also 
interrogated for their mechanical properties, in 
particular membrane bending elasticity, using 
thermal fluctuation spectroscopy as described in 
more detail earlier (63,64). In brief, individual 
RBCs (n = 9) were recorded using phase contrast 
microscopy (Leica DMLFS upright microscope 
equipped with 63× PL Fluotar objective). Video 
sequences (about 1000 frames) of fluctuating 
RBCs were recorded at an exposure time of 10 ms 
using a QImaging QIClick CCD camera attached 
to the microscope and interfaced with a computer, 
and each frame was analysed by a sub-pixel 
precision algorithm to obtain a series of 2D 
equatorial contours. Each contour was 
decomposed into a Fourier series used 
subsequently to calculate the thermal fluctuation 
spectrum of the entire contour sequence as 
described in (63,64). The bending elastic modulus 
of the membrane was obtained by fitting a flat-
membrane model to the experimentally obtained 
thermal fluctuation spectrum (a full discussion of 
the bases of this methodology can be found in 
(64)). For these experiments, 5 µL samples of 
fresh blood was collected from a healthy volunteer 
using a pin-prick lancet and immediately 
suspended in 1 mL DPBS/BSA. A small volume 
(approximately 20 µL) of this suspension was 
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introduced in an imaging chamber that consisted 
of a microscope slide and a glass coverslip spaced 
apart by two strips of Parafilm® (Pechiney Plastic 
Packaging, USA) along the long edges of the slide, 
bonded together by heating briefly on a hot plate. 
Within a few minutes the cells settle down onto 
the bottom of the chamber (due to their slightly 
higher density than that of the surrounding buffer), 
which allowed their fluctuations to be recorded 
before introducing the toxin solution (DPBS/BSA 
containing PLY at a final concentration of 59 
ng/mL) by placing excess solution on one side of 
the chamber and pulling it through with filter 
paper introduced to the opposite side.  
Monitoring the changes in the radius of 
RBCs exposed to PLY over timeChanges in the 
radius of the equatorial contour of RBCs are an 
indicator for the onset of lysis. Therefore, we 
measured the radius of individual cells before and 
after introducing the toxin solution into the 
imaging chamber using the same methodology as 
for the thermal fluctuation analysis (in fact, radius 
evaluation is a part of the Fourier representation of 
the contour). In all experiments, cell membrane 
radii were initially recorded while in DPBS/BSA 
after the cells have stabilised on the bottom of the 
chamber. The buffer was then exchanged with 
buffer containing PLY (59 ng/mL) and RBCs were 
recorded at regular time intervals (typically every 
2 minutes for a period of up to 30 minutes). 
Measurement of Hba1c levels in RBCs 
from diabetic individualsLevels of glycated 
haemoglobin (HbA1c) were determined with the 
Gold standard Ion-Exchange method using the 
Tosoh G8 HPLC Analyzer, (Tosoh Bioscience, 
South San Francisco, CA). 
Measurement of the modulus of shear 
elasticityTo measure the RBC shear elastic 
modulus, we employed the micropipette aspiration 
method. In brief, a micropipette is brought in close 
proximity to a cell, which is then partially 
aspirated into the pipette by applying small suction 
pressure. Subsequent incremental increases in the 
suction pressure leads to a stepwise aspiration of 
the cell membrane into the pipette, which allows 
the establishment of the relationship between the 
applied suction pressure, P, and the projected 
length of the membrane inside the pipette, L. The 
shear elastic modulus, µ, can then be evaluated 
from such dependences according to the following 
equation (65,66):  
∆𝑃𝑅p = 𝜇 [𝐾1 (
𝐿
𝑅𝑝
) − 𝐾2]  (1)  
where Rp is the pipette radius, and K1 = 2.45 and 
K2 = 0.603 are numerical constants. Equation 1 is 
valid for 1  L/Rp  4.   
 Micropipettes were drawn from glass 
capillaries of 0.86 mm internal diameter (Harvard 
Instruments GC 150-11) using a microelectrode 
puller (Micro Instruments Ltd, Oxford). The end 
of the pipette was then manually forged with a 
heated filament until a smooth aperture was 
produced with typical diameters of 1 – 2 µm. The 
pipette was filled with buffer and attached to a 
pressure-generating apparatus capable of 
controlling the suction pressure via careful 
adjustments of the height of a buffer reservoir. The 
micropipette was then mounted on a hydraulically-
driven micromanipulator (Narishige Co. Ltd) and 
its tip was introduced into the chamber containing 
the cell suspension. Images were acquired using a 
Leica DMLFS upright microscope (40× long 
working distance objective), a video camera (JVC 
KY-F55B) and acquisition software (AcQuis Bio 
3.01).    
 The University of Exeter Medical School, 
NIHR Exeter Clinical Research Facility, Diabetes 
and Vascular Medicine Centre provided blood 
samples from individuals with diabetes (n = 12) 
and healthy (n = 14) subjects, stored at 4 °C in 9.5 
mL heparinised tubes and used within 48 hours. 
The individuals with diabetes were males over the 
age of 45 with no known diabetic complications 
and neither on insulin nor on metformin therapy. 
Control samples were obtained from age-matched 
healthy subjects.   
Statistical analysesThe software 
GraphPad Prism 6 (GraphPad Software, La Jolla, 
USA) was used to perform statistical analysis. In 
all analyses, P values of < 0.05 were considered 
significant. All data represent the means and 
standard deviations of three independent 
experiments performed in triplicate, unless stated 
otherwise. 
 
RESULTS 
Variation of response to pneumolysin 
within a population of human RBCsIn the initial 
experiments, we sought to establish the behaviour 
of human RBC populations in response to PLY. 
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Fresh RBCs from healthy individuals (n = 17) 
were incubated with purified recombinant PLY 
(118 ng/mL) and the time course of haemolysis 
induced by the toxin on individual cells within 
each population was monitored by phase contrast 
microscopy. Figure 1A shows representative phase 
contrast images of a population of RBCs exposed 
to PLY at time points 0, 15 and 30 minutes. In 
phase contrast, lysed cells appear as dark circles 
while live cells appear with a distinctive halo 
around their edges. Figure 1B shows the average 
(± SEM) haemolysis time profiles of 17 different 
donations treated with PLY. As evident from these 
results, the interaction between RBCs and PLY is 
characterised by a sigmoidal curve, which 
suggests a considerable degree of variability in the 
RBC response. At the toxin concentration used, a 
lag phase of approximately 3 minutes (on average) 
was followed by lysis where most cells lysed by 
30 minutes. Experiments carried out in the absence 
of PLY did not show any noticeable changes in the 
number of live cells on the time scale of the assay 
(data not shown).  
In order to characterise the variability of 
RBC response to PLY within the same population, 
we compared the lysis behaviour of RBCs exposed 
to PLY for each of the 17 individual samples.  
Figure 1C shows three representative individual 
haemolysis time profiles from different healthy 
individuals. It can be seen that, although all 
samples exhibit the characteristic S-shaped curve, 
there are considerable quantitative variations 
between the individual populations. Figure 1D 
shows a dot plot of the percentage of live RBCs 
from 17 healthy individuals 30 minutes after 
exposure to PLY, where on average 6.6 % ± 1.7 % 
(SEM) of RBCs remain resistant to PLY-induced 
lysis, despite all cells having been subjected to the 
same concentration of toxin.  
Another important observation illustrated 
in Figure 1C is the considerable degree of 
variability of RBC response to PLY within the 
same population, in which the time scale for cell 
lysis could differ by many minutes, despite the 
fact that all cells were derived from the same 
individual. To further investigate the variation of 
response to PLY within a population of RBCs, we 
monitored the changes in the radius of RBCs 
exposed to PLY over time. This revealed two 
distinct stages of interaction (Figure 2). In the first 
stage (lasting different periods for different cells) 
the radius remains relatively constant. This is 
followed by a rapid drop in the radius in the 
second stage of interaction that corresponds to cell 
lysis. Figure 2 shows typical time courses of the 
radius change for two RBCs from the same sample 
exposed to PLY, where the onset of cell lysis, 
marked by arrows, differs between the two cells 
by some 21 minutes. These results prompted us to 
further investigate the factors that influence the 
diversity of response to PLY within a population 
of cells. The experiments that follow were 
designed to address this question.   
The variation of response to PLY within a 
population of human RBCs correlates with the 
amount of toxin bound to the membraneTo 
investigate if there is a correlation between the 
RBC response to PLY and the amount of toxin 
bound to the membrane, we incubated RBCs with 
recombinant GFP-tagged PLY (eGFP-PLY). 
Figure 3A shows representative DIC and GFP 
fluorescence images obtained after exposure of 
RBCs to eGFP-PLY (0.67 µg/mL). The GFP 
fluorescence intensity of cells (n = 38) was 
measured 2 minutes after exposure to toxin. Most 
cells exposed to the toxin lysed within 2 minutes 
of exposure, indicated by the appearance of faint 
circles in the DIC image. However, some cells 
showed prolonged resistance to the toxin and in 
the DIC image appeared with a halo around their 
edges. Statistical analysis using Student t test 
revealed that cells with prolonged resistance to the 
toxin showed significantly lower GFP 
fluorescence intensity values compared to cells 
that lysed within 2 minutes of exposure to toxin, 
indicating that variation of cell response to PLY 
within a population of RBCs correlates with the 
amount of toxin bound to the membrane (Figure 
3B). The punctate pattern of fluorescence on the 
RBC membrane probably corresponds to high 
molecular weight aggregates of the GFP-labelled 
toxin in the form of close-packed pores that have 
also been observed for the small β-PFTs, lysenin 
and epsilon toxin (67-69). The pores can also be 
observed by analytical ultracentrifugation of 
membranes solubilised from toxin treated cells or 
by electron microscopy (data not shown). 
Effect of cell morphology on susceptibility 
of RBCs to PLYTo investigate the effect of cell 
morphology on the susceptibility of RBCs to PLY, 
RBCs from 17 healthy individuals were incubated 
with PLY, as described above, and lysis was 
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monitored by phase contrast microscopy. The 
shape of RBCs in each population was assessed 
using ImageJ and the percentage of lysed 
discocytes and stomatocytes 15 minutes after 
exposure to PLY was determined (Figure 4A). 
Statistical analysis using Mann–Whitney t test 
revealed that stomatocytes are more susceptible to 
PLY relative to discocytes, indicated by increased 
percentage of lysed cells 15 minutes after 
exposure to toxin (Figure 4A).  
To investigate if the increased sensitivity 
of stomatocytes relative to discocytes correlates 
with increased levels of toxin bound to the 
membrane, we incubated live RBCs with eGFP-
6PLYL363A, a non-lytic variant of recombinant 
eGFP-PLY with preserved binding activity (49). 
As shown in Figure 4B, stomatocytes showed 
significantly higher GFP fluorescence intensity 
values compared to discocytes.  
In a separate group of experiments, we 
performed DIC and fluorescence imaging of 
echinocytic RBCs (formed spontaneously in the 
blood sample) incubated with eGFP-6PLYL363A 
(1.67 µg/mL) for 2 minutes.  As can be seen from 
Figure 4C, we observed clusters of eGFP-
6PLYL363A bound preferentially to the spikes of 
the echinocytes, where the curvature of the 
membrane is high. 
Simulated oxidative stress, artificial aging 
and membrane lipid scrambling of RBCs leads to 
changes in susceptibility to PLYTo determine 
whether the variation of cell response to PLY 
might be due to differences in the biochemical 
status of the RBC membrane, we selectively 
modified the membrane using four different 
treatments. Oxidative stress was simulated by 
exposing RBCs to either hydrogen peroxide 
(H2O2, 100 µM) or cumene hydroperoxide 
(cumOOH, 100 µM). These two oxidants were 
used to selectively target different cell 
constituents. Hydrogen peroxide is water-soluble 
and upon addition to the cell suspension it 
permeates the plasma membrane relatively quickly 
and partitions in the cytoplasm, thus targeting 
mainly haemoglobin (64,70). In contrast, 
cumOOH is membrane-soluble and partitions 
predominantly into the lipid bilayer due to its 
hydrophobicity, where it is able to cause oxidative 
damage to lipids as well as to membrane-bound 
proteins and to the membrane skeleton (64,70). To 
simulate aspects of the aging process in RBC, we 
exposed cells to the steroid DHEA (35 µM), as 
described in the Experimental Procedures section. 
In a separate series of experiments, membrane 
lipid scrambling was induced using calcium 
ionophore A23187 (20 µM) in the presence of 
calcium chloride (0.9 mM).  
Figure 5 is a representative summary of 
the obtained results, along with a control of 
untreated cells. The typical sigmoidal response is 
observed again. However, there are considerable 
quantitative differences between the different 
treatment protocols. Treatment with H2O2 had no 
effect on the sensitivity of RBCs to PLY (the 
haemolysis profile in this case was similar to the 
control sample), while cumOOH-induced 
oxidative stress resulted in increased resistance to 
PLY relative to control cells, indicated by the low 
percentage of lysed cells over the time course of 
the experiment (30 minutes). A similar effect was 
observed in cells treated with calcium ionophore 
A23187. In contrast, artificially aged cells treated 
with DHEA exhibited higher susceptibility to PLY 
relative to control cells, indicated by the increased 
percentage of lysed cells over the time course of 
the experiment. 
Increased resistance of calcium ionophore 
A23187-treated RBCs to PLY corresponds to 
reduced toxin bindingThe drastic changes in 
membrane lipid composition and loss of 
asymmetry between the two leaflets of the RBC 
membrane induced by the calcium ionophore 
A23187 treatment required further investigation to 
assess the binding affinity of PLY to scrambled 
membranes. First, we labelled calcium ionophore 
A23187-treated and control RBCs with 
AlexaFluor® 594-annexin V.  Since annexin V 
binds to phosphatidylserine (PS), the expectation 
was that only cells in which PS is transferred to 
the outer membrane leaflet will become labelled 
with annexin V (for healthy RBCs PS is 
exclusively located in the inner membrane leaflet). 
These preparations were then incubated with either 
eGFP-6PLYL363A or buffer only and toxin 
binding was analysed by flow cytometry. 
The first group of experiments was carried 
out on annexin V-labelled cells treated with 
calcium ionophore A23187 or ethanol aqueous 
solution (as control) before exposure to toxin. 
Flow cytometry analysis of dot plots that reflect 
cell shape revealed that calcium ionophore 
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A23187-treated cells had altered cell morphology 
relative to control cells, with reduced forward 
scatter (FSC), indicating reduced size, and a 
narrow range of side scatter (SSC), indicating 
echinocytic morphology (71) (Figure 6A). Further 
microscopy analysis revealed projections of the 
cell membrane in calcium ionophore A23187-
treated cells, leading to echinocytes (Figure 6B). 
Fluorescence analysis of calcium 
ionophore A23187-treated cells revealed that 36.2 
% of cells were labelled with Alexa Fluor® 594-
annexin V (Figure 7B, bottom right panel), 
indicating transfer of PS to the outer membrane 
leaflet, while control cells showed only 
background red fluorescence of 0.09 % (Figure 
7A, bottom right panel), indicating that PS is 
located exclusively in the inner membrane leaflet. 
The second group of experiments was 
carried out on annexin V-labelled control and 
A23187-treated RBCs after exposure to eGFP-
6PLYL363A. Flow cytometry analysis of annexin 
V-labelled control cells exposed to eGFP-
6PLYL363A showed green fluorescence in 99.5 % 
of cells (Figure 7C, top left panel), indicating 
eGFP-6PLYL363A binding to most cells. Annexin 
V-labelled calcium inonophore A23187-treated 
cells exposed to eGFP-6PLYL363A showed green 
fluorescence in 59.1% of cells (Figure 7D, top left 
panel) and double fluorescence of green and red in 
39.2 % of cells (Figure 7D, top right panel), 
indicating eGFP-6PLYL363A binding to RBCs 
with both externalised and non-externalised PS. 
However, double fluorescence plots of red and 
green fluorescence show that the green 
fluorescence intensity in annexin V-labelled 
calcium ionophore A23187-treated cells exposed 
to toxin is reduced in comparison to annexin V-
labelled control cells exposed to toxin (top left 
panels of Figure 7D and C, respectively). This 
tendency is especially visible for calcium 
ionophore A23187-treated cells with externalised 
PS (Figure 7D, top right panel). These results 
indicate that increased resistance of A23187-
treated cells to PLY is most probably due to 
reduced toxin binding to membranes with 
scrambled lipids. 
Differences in the membrane physical 
properties of individual cells within a population 
of human RBCs are correlated with their 
susceptibility to PLYThe physical properties of 
the lipid bilayer membrane, such as membrane 
elasticity and its electrostatic status, are likely 
determinants of the susceptibility of cells to toxin, 
as they have been shown to contribute to, as well 
as control, the interactions between the plasma 
membrane and various proteins (72-74). This 
motivated us to investigate whether differences in 
the membrane physical properties of individual 
cells within a population of RBCs are correlated 
with their susceptibility to PLY. We measured the 
membrane bending elastic modulus (a primary 
measure of the mechanical compliance of the lipid 
bilayer (75)), the membrane electrostatic dipole 
potential (76,77) and the membrane electrostatic 
surface potential (60,61) for a number of 
individual cells within a population of RBCs 
before toxin exposure. The buffer surrounding the 
cells was then exchanged with buffer containing 
toxin and the time to lysis, i.e. the period of time 
the cell survived intact and without haemolysis 
after the addition of toxin, was monitored for each 
cell by microscopy. 
Figure 8A shows the dependence of the 
membrane bending elastic modulus (in units of 
kBT, where kB is the Boltzmann constant and T is 
the absolute temperature) on the time to lysis for 
nine individual cells. There is a clear correlation 
between these two parameters, where cells that are 
more rigid with respect to bending show reduced 
time to lysis, indicating increased susceptibility to 
the toxin’s lytic activity.  
In separate experiments, using ratiometric 
fluorescence microscopy measurements on Di-8-
ANEPPS-labelled RBCs, we found a similar 
correlation between the membrane dipole potential 
and the time to lysis, as illustrated in Figure 8B. 
Higher dipole potentials appear to be correlated 
with reduced time to PLY-induced lysis.  
Finally, we measured the membrane-
associated fluorescence intensity of FPE-labelled 
RBCs before toxin exposure in order to evaluate if 
there is a correlation between the membrane 
electrostatic surface potential and the 
susceptibility of RBCs to PLY-induced lysis. 
Figure 8C shows the measured membrane-
associated fluorescence intensity as a function of 
time to lysis.  Differences in the fluorescence 
intensity of FPE are indicative of the degree of 
natural variations in the magnitude of the surface 
electrostatic potential of the (negatively charged) 
RBC membrane. FPE is sensitive to changes in the 
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surface potential due to a shift in the protonation-
deprotonation equilibrium (61), resulting in higher 
fluorescence intensities when the magnitude of the 
potential is lower. From these experiments we 
conclude that cells exhibiting lower magnitude of 
the surface potential (hence lower surface density 
of negative charges) are more susceptible to toxin. 
Conversely, more negative membranes show 
increased resistance to lysis.   
Correlation between levels of glycated 
haemoglobin (Hba1c) and susceptibility of RBCs 
from individuals with diabetes to PLYNext, we 
sought to establish whether the response to PLY in 
RBCs derived from diabetic subjects correlates 
with levels of glycated haemoglobin (Hba1c), 
which is elevated in diabetes; the higher the 
HbA1c levels, the greater the risk of developing 
diabetes-related complications. We investigated 
samples from 36 individuals (23 of whom were on 
metformin therapy, whilst 13 were not) for RBC 
susceptibility to PLY-induced lysis. Diabetic 
RBCs were exposed to PLY (118 ng/mL) and the 
percentage of live cells after exposure to toxin for 
30 minutes was plotted against Hba1c levels. For 
the subset of individuals who were not treated with 
metformin (Figure 9A), there is a statistically 
significant positive correlation between the 
percentage of live cells and Hba1c levels, 
indicating that RBCs from individuals with 
diabetes with increased levels of Hba1c are more 
resistant to PLY. For the other subset (individuals 
to whom metformin was prescribed), this 
correlation was much weaker, making the 
dependence statistically insignificant (Figure 9B).  
RBCs from individuals with diabetes show 
increased resistance to PLY and PFO-The 
significant positive correlation between Hba1c 
levels and PLY resistance of RBCs from 
individuals with diabetes not on metformin 
therapy motivated us to compare the susceptibility 
of RBCs from healthy and diabetic individuals to 
two members of the CDC family of PFTs: PLY 
and PFO. Fresh RBCs from healthy individuals (n 
= 17) and individuals with diabetes not on 
metformin therapy (n = 13) were incubated with 
purified recombinant PLY (118 ng/mL) or PFO 
(72 ng/mL) and cell lysis was monitored by phase 
contrast microscopy. Figure 10 shows the average 
(± SEM) haemolysis time profiles of the cells 
treated with the toxins. RBCs from diabetic 
individuals showed increased resistance to both 
PLY (Figure 10A) and PFO (Figure 10B), 
indicated by a right-shift of the haemolysis time 
profiles relative to healthy RBCs. At the toxin 
concentrations used, the time required to lyse 50% 
of the RBCs from individuals with diabetes has 
increased by approximately 6 minutes (on 
average) relative to control, healthy cells.  
Diabetic RBCs exhibit increased 
membrane stiffnessIn a separate set of 
experiments, we sought to establish whether the 
mechanical properties of the RBC plasma 
membrane are altered in diabetes. Using the 
micropipette aspiration method, we measured the 
modulus of shear elasticity of RBCs derived from 
diabetic subjects (n = 12) neither on insulin nor on 
metformin treatment compared to healthy, age-
matched controls (n = 14). A summary of the 
measurements is shown in Figure 11, from which 
the modulus of shear elasticity was evaluated. The 
average shear modulus for the controls was 5  1 
µN/m, whilst for the diabetic group the average 
value was significantly higher, 12  2 µN/m.  
 
DISCUSSION 
Membrane biophysical properties and cell 
susceptibility to PLYThe results obtained in this 
study paint a complex landscape of biophysical 
factors affecting the interaction between PLY and 
RBCs. Single cell studies carried out to assess the 
effect of the physical properties of the membrane 
on cell susceptibility to toxin (Figure 8) revealed 
that membrane elasticity and electrical properties 
in healthy RBCs are correlated with their 
susceptibility to PLY-induced lysis.  
Surface charge density (and therefore 
surface potential) will modify the interactions of 
the membrane with charged molecules. Whilst the 
detailed charge distribution on the surface of a 
PLY monomer is complex (Figure 12), the overall 
charge of the molecule is -15 (78). This, to the 
lowest approximation, would explain the observed 
dependence in Figure 8C, which suggests that cells 
that naturally possess lower (negative) surface 
potential are more prone to haemolysis, probably 
due to the reduced electrostatic repulsion between 
the molecule of PLY and the RBC membrane. The 
reason for the marked electronegative potential of 
PLY in contrast to other CDCs is unclear (33). 
The membrane dipole potential has its 
origins in the alignment of the lipid molecules 
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(containing a number of dipoles mainly in the 
headgroup region) in the plane of the membrane 
and the orientation of water molecules in the 
immediate vicinity of the lipid headgroups (79-
81). This potential has been reported to affect 
protein function (59), as well as insertion and 
secondary structure formation of peptides (76). 
Here we have shown that healthy RBCs naturally 
characterised by higher magnitudes of the 
membrane dipole potential are more susceptible to 
PLY (Figure 8B) and to the related toxin PFO 
(data not shown), probably due to increased 
cholesterol levels in these cells (see below) (59). 
In a similar trend, cells that exhibit higher bending 
rigidity of their membranes are easier to lyse by 
PLY.  However, we must emphasise that these two 
parameters are not the sole and direct determinants 
of lytic resistance per se. This can be seen in 
comparison with cells pretreated with cumOOH 
(Figure 5). We have previously shown that 
treatment of RBCs with cumOOH increased both 
membrane bending elastic modulus (64) and 
membrane dipole potential (77), yet these cells are 
much more resistant to toxin compared to healthy 
cells, for which higher bending rigidity and dipole 
potential meant lower resistance to PLY (Figure 
8A and B, respectively). Therefore, the origins of 
the correlations between these two properties and 
susceptibility to PLY in healthy cells should be 
sought in a common underpinning factor, such as 
the variations in molecular composition and 
supramolecular organisation of the lipid 
membrane, which may alter the cell resistance to 
toxin, as well as the membrane physical 
properties.   
Factors affecting cell susceptibility to 
PLYOne of the likely factors suggested by the 
cell membrane modification studies (see below) is 
the age of the individual cells within the 
population. As a measure of the time spent by the 
cell in an environment characterised by chemical 
stresses, cell age is likely to alter the membrane 
physical properties. Indeed, a number of studies 
reported that RBC deformability decreases with 
cell age (for a comprehensive summary see (82)). 
However, many of these measurements are 
method-dependent and the reported quantities are 
often ambiguously defined. In addition, changes in 
the overall cell deformability are generally related 
to changes in viscosity of the cytoplasm, 
membrane fluidity and membrane elasticity (82), 
which is further characterised by bending, shear 
and area deformations (7). The two parameters we 
measure in this work, membrane bending modulus 
and dipole potential, reflect primarily the 
properties of the lipid bilayer, but to the best of 
our knowledge there are no comprehensive studies 
as to how these two properties would change with 
cell age. As a first approximation to the process of 
aging, we measured the bending elastic modulus 
of cells treated with DHEA, but found no 
significant alterations from untreated cells (data 
not shown). DHEA inhibits glucose-6-phosphate 
dehydrogenase (G6PD) activity, and there are 
contradictory reports on RBC deformability in 
G6PD-deficient subjects (83-85), but again, the 
methods used to assess cell deformability did not 
necessarily mean measuring the membrane 
bending elastic modulus. A detailed study of the 
effect of aging on RBC membrane physical 
properties (bending, shear, area elastic moduli and 
membrane electrostatic potentials) falls beyond the 
scope of the present study. Even though the 
membrane modification studies suggest that cell 
aging is a factor determining cell susceptibility to 
toxin, it would be too speculative to also attribute 
the correlations we established in Figure 8A and B 
solely and exclusively to RBC age. It is also 
notable that we found no significant correlation 
between the age of the healthy donors (a parameter 
different from individual cell age in the same 
population) and the susceptibility of their RBCs to 
PLY (data not shown). Other factors are bound to 
play a significant role.  
One of these factors is likely to be the 
membrane cholesterol content. It has been 
established that the presence of membrane 
cholesterol is an essential condition for successful 
insertion of PLY into membranes (1) and 
depletion of membrane cholesterol impairs the 
haemolytic activity of PLY (52). Natural variation 
in cholesterol content between different cells could 
then be responsible for the different binding of 
PLY to RBCs (Figure 3); our measurements of 
membrane bending modulus (Figure 8A) and 
membrane dipole potential (Figure 8B) point in 
the same direction. It is well known that inclusion 
of cholesterol in bilayer membranes of lipids with 
either two saturated chains or one saturated and 
one monounsaturated chain leads to increase of 
their bending elastic modulus (86-90). In 
membranes, cholesterol intercalates between lipid 
 at The U
niversity of Birm
ingham
 on D
ecem
ber 2, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Red Blood Cell Properties and Susceptibility to Pneumolysin 
12 
 
chains to form a highly ordered but laterally 
mobile liquid ordered phase, which is believed to 
be the basis of the membrane lipid rafts (91). This 
liquid ordered phase is characterised with higher 
magnitudes of its membrane dipole potential 
(59,92). Thus, the fact that stiffer membranes and 
membranes with higher dipole potential are more 
susceptible to lysis is likely to reflect higher 
cholesterol content. 
Whilst it is recognised that CDC binding 
to the lipid membrane requires the presence of 
cholesterol, it is also clear that its role in this 
process is complicated (93,94), with significant 
differences (both quantitative and qualitative) 
between different CDC toxins. For example, 
studies using PFO revealed that membrane binding 
depends on the availability of ‘free cholesterol’ at 
the membrane surface and does not correlate with 
the presence of detergent-resistant domains (93). 
In contrast, PLY has been reported to bind to 
cholesterol-rich lipid raft microdomains in corneal 
epithelial cells (95). Such differences suggest that 
the composition and organisation (and hence 
physical properties) of the lipid bilayer itself is 
likely to be a key regulator of the interaction of 
CDCs with the membrane. 
We also found that cell morphology has 
an effect on membrane susceptibility to PLY, with 
discocytes being more resistant than stomatocytes 
(Figure 4). Interestingly, in a previous study 
investigating the dependence of the membrane 
dipole potential in RBCs and ghosts on membrane 
curvature (77), we found that stomatocytes are 
characterised with higher membrane dipole 
potentials compared to discocytes, which could 
also have an effect on PLY recruitment to the 
membrane (cf. Figure 8B). Additional imaging 
experiments with echinocytes revealed that toxin 
distribution along the surface of the echinocytic 
cells was non-uniform, with the majority of toxin 
clustering onto the highly curved membrane 
projections (Figure 4C). These observations 
suggest that PLY may have curvature preference 
when binding to or diffusing along the membrane. 
Further studies would be necessary to clarify 
whether PLY has an intrinsic curvature preference 
or the effect is caused by curvature-driven sorting 
of lipids in the plasma membrane (96). If this is 
the case, such spatially restricted distribution may 
serve to effectively increase the local toxin 
concentration, leading to shorter diffusion 
distances and faster formation of oligomers, hence 
shorter lysis times. 
Membrane modification and cell 
susceptibility to PLYIt has previously been 
shown that reduction of extracellular calcium 
strongly enhances the lytic capacity of PLY due to 
increased membrane binding (97). One of the main 
findings of this study suggests that cell 
susceptibility to PLY also critically depends on the 
oxidative and/or other chemical stress the 
membrane has been subjected to prior to 
interaction with the toxin (Figure 5). In addition, it 
demonstrates non-universality of the effect of 
different oxidative agents, since the outcome, in 
terms of cell resistance to toxin, critically depends 
on the mode of action of each oxidant. This is 
evident by comparing the effects of the two 
oxidative agents used, H2O2 and cumOOH. H2O2 
is water-soluble and readily partitions in the 
cytoplasm once it has crossed the lipid bilayer, 
where its primary target is haemoglobin. 
Oxidation and denaturing of haemoglobin leads to 
the formation of spectrin-globin complexes, 
changes spectrin network organisation and also 
causes clustering of the transmembrane protein 
Band 3 (64,98-101). Although H2O2 may affect the 
molecular organisation in the lipid bilayer (99), the 
transbilayer lipid distribution is not affected and 
its overall effect on the lipid bilayer is limited 
(64,77,99), hence the lack of effect on the 
susceptibility of RBCs to PLY. On the other hand, 
direct oxidation of the lipid bilayer membrane 
with the membrane-bound cumOOH drastically 
affects the PLY-RBC interactions and makes the 
membrane much more resistant to toxin. This 
could be due to the chemical modification of PLY 
receptors on the membrane surface (40) and/or 
oxidation of cholesterol that could modulate the 
conformation of glycans necessary for the 
successful binding of the toxin to the RBC 
membrane (102). Direct cholesterol oxidation 
(103) will also affect the lateral microdomain 
organisation of the lipid membrane (104-106), 
which could impair membrane insertion of the 
toxin, since PLY has been reported to bind to 
cholesterol-rich lipid raft microdomains (95). As a 
result, the membrane is rendered more impervious 
to toxin. Lipid oxidation also has an effect on the 
physical state of the membrane. We have 
previously shown that cumOOH leads to tighter 
in-plane lipid packing as demonstrated by an 
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increase in the membrane dipole potential (77), as 
well as increased membrane bending and shear 
rigidity (64) (for a discussion of the membrane 
physical properties see above). Such changes in 
lipid packing may result in reduced ability of the 
toxin to insert into the plasma membrane. 
In contrast to the effect of cumOOH, 
aging cells artificially using DHEA leads to lower 
resistance to PLY. DHEA inhibits glucose-6-
phosphate dehydrogenase (G6PD) activity, which 
results in reduced levels of NADPH, an essential 
molecule in the cell’s antioxidant defence system. 
Therefore, these cells are characterised with higher 
exposure to oxidative stress (presumably under 
conditions more similar to those in vivo), yet their 
response to PLY differs from both H2O2 and 
cumOOH-treated cells. This, once again, 
demonstrates that the general term ‘oxidative 
stress’ is insufficient in describing the effect of 
oxidative agents on membrane response to toxin 
and that the mechanism of action of each oxidant 
should be considered on a case-by-case basis.  
The final membrane modification we 
investigated, lipid scrambling caused by calcium 
ionophore A23187, led to increased cell resistance 
to PLY that correlates with impaired toxin 
binding. We designed this experiment to mimic 
aspects of eryptosis (the analogue of apoptosis in 
nucleated cells), which is characterised, amongst 
other processes, by lipid scrambling and exposure 
of PS on the outer leaflet of the lipid bilayer (58). 
Our results show that lipid scrambling is a factor 
for increased cell resistance to not only PLY 
(Figure 5) but also to the related toxin PFO (data 
not shown), which suggests that cells set on the 
path of programmed death are also less likely to 
haemolyse under the lytic action of the toxin. This 
could be understood in terms of the asymmetry of 
the RBC lipid bilayer membrane. In human RBCs 
lipid species, such as PS and 
phosphatidylethanolamine (PE), are much more 
abundant in the inner, cytoplasmic leaflet, whereas   
phosphatidylcholine (PC) and sphingomyelin 
(SM) are found in larger concentrations in the 
outer leaflet (107). Scrambling of lipids would 
change the lipid composition in the leaflets as well 
as their lateral lipid organisation. This will 
ultimately affect the interaction between the toxin 
and the membrane (see Figure 7), since the toxin is 
expected to be attuned to effective interactions 
with the outer surface of the cell membrane, with 
which it establishes the first contact.  
These observations lead to the conclusion 
that at least one of the factors for the variability in 
the response of cells within the same population to 
toxin is likely to be the chemical and/or oxidative 
prehistory of each individual cell, which would be 
determined by the cell age in the circulation and 
the relevant health status of the individual. Cell 
modifications as a result of disease (e.g. conditions 
characterised by high levels of oxidative stress, 
such as diabetes (108)) may lead to altered 
susceptibility to virulence factors, consistent with 
our findings that RBCs from individuals with 
diabetes show increased resistance to PLY and 
PFO relative to healthy RBCs (Figure 10). 
Susceptibility to CDCs may also be altered in 
diseases that affect the RBC cholesterol content, 
such as acute coronary syndrome where the 
cholesterol content of the erythrocyte membranes 
is increased (109) or in diseases that are 
characterised by PS externalization, such as sickle 
cell anaemia (110), sepsis (111) and systemic 
sclerosis (112).  
Susceptibility of RBCs from individuals 
with diabetes to PLYOur cell modification 
studies provide a framework for understanding the 
diversity of response to PLY in RBCs from 
individuals with diabetes. We found that RBCs 
from individuals with higher levels of Hba1c, 
which presumably have been subjected to higher 
glucose concentrations or resided in 
hyperglycaemic milieu for longer periods of time, 
were more resistant to the toxin’s lytic action 
(Figures 9 and 10A). Increased resistance to PLY 
in RBCs from individuals with diabetes and higher 
levels of Hba1c could be understood in terms of 
elevated oxidative stress, to which the cell 
membrane is exposed in diabetes, and its 
consequent biochemical and biophysical 
modifications. Numerous studies have 
demonstrated that oxidative stress levels are higher 
in diabetes and this plays an important role in the 
progression of the disease and its complications 
(113,114). This is a consequence of the elevated 
glucose levels, leading to abundance of free 
radicals generated through glucose oxidation as 
well as non-enzymatic glycation of proteins and 
their subsequent oxidation (114). As discussed 
above, higher levels of oxidative stress would 
cause modification of the bilayer lipid membrane 
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(including lipids, cholesterol and membrane 
proteins) and/or PLY receptors on the surface, 
which in some cases may lead to increased 
resistance to PLY (cf Figure 5). In this context, 
Hba1c can be considered as a measure of the 
oxidative stress levels, which the cells have been 
exposed to. Further evidence for the altered RBC 
membrane physical properties in diabetes is 
presented in Figure 11, showing that for diabetic 
cells, the membrane shear elastic modulus is more 
than twice the value of age-matched controls. Such 
stiffening of the membrane is suggestive of the 
involvement of oxidative processes, as previously 
demonstrated (64,99,115), and supports our 
conclusion that increased haemolytic resistance of 
RBCs from diabetic individuals is due to oxidative 
modifications of their membranes. 
To the extent that the RBC membrane is 
representative of plasma membranes of other cell 
types, our studies on RBCs from individuals with 
diabetes suggest that the increased association of 
S. pneumoniae with disease in individuals with 
diabetes may not necessarily be related to the 
direct and immediate haemolytic action of PLY. It 
is known that diabetic patients often have impaired 
immune functions (116) and this may outweigh 
the increased resistance of cells to the action of the 
toxin, providing other routes through which the 
adverse effects of S. pneumoniae could occur. 
Alternatively, the reduced haemolytic activity of 
PLY in individuals with diabetes may favour the 
initial survival and proliferation of S. pneumoniae 
in the blood. Such an interpretation is supported 
by a recent study showing that PLY with low 
hemolytic activity conferred an early growth 
advantage to S. pneumoniae in the blood compared 
to strains expressing PLY with full haemolytic 
activity (117). PLY also has non-cytolytic, 
complement-activating properties that act 
independently of its cytolytic activity (118,119). 
It is important to note the differences 
between the two subsets of diabetic individuals 
investigated in this study (Figure 9A and B). The 
dependence of the susceptibility of RBCs to PLY 
on Hba1c appears to be much weaker in 
individuals treated with metformin (to the point of 
being statistically insignificant). Metformin is a 
common anti-hyperglycaemic agent for the 
treatment of type 2 diabetes and it is thought to 
help prevent complications by increasing cell 
sensitivity to insulin (120), thereby providing 
satisfactory glucose control. However, there is 
evidence that metformin may offer further benefits 
by reducing the levels of glyoxal and 
methylglyoxal and preventing the formation of 
advanced glycation end products (121,122). 
Recent studies have also suggested that metformin 
could reduce the production of reactive oxidative 
species (120,123). Our previous in vitro 
experiments on RBC membrane elasticity 
demonstrated that, whilst glycated RBCs are more 
susceptible to oxidative stress than normal cells, 
the metformin is able to ameliorate considerably 
the increased vulnerability of glycated cells to 
oxidative stress (124). These results suggest that 
oxidation-induced membrane modifications may 
be significantly reduced in the presence of 
metformin, and this could be the main factor 
explaining the difference in the response of 
diabetic cells to toxin between the two groups 
(Figure 9A and B).   
Conclusion-In conclusion, our studies 
indicate that the diversity of response to PLY 
within a population of RBCs is influenced by the 
biophysical, biochemical and morphological 
properties of the plasma membrane and is also 
correlated to membrane modifications in diabetes. 
These results are not only relevant to 
understanding the interactions between pore-
forming toxins and RBCs but also (to the extent 
that the RBC membrane serves as a model of 
eukaryotic cell membranes) to understanding the 
behaviour of toxins in tissues. We believe that our 
findings are relevant to other CDCs and similar 
methodology can readily be employed for 
assessing cell susceptibility to a variety of other 
pore-forming toxins.  
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FIGURE LEGENDS 
 
FIGURE 1. Variation of RBC response to PLY. (A) Representative phase contrast images of RBCs 
exposed to PLY. Scale bar, 5 µm. (B) Average (± SEM) time course of haemolysis induced by PLY (118 
ng/mL) in RBCs from 17 healthy individuals. (C) Individual time courses of haemolysis induced by PLY 
(118 ng/mL) in RBCs from three healthy individuals. (D) Dot plot of the percentage of live RBCs 30 
minutes after exposure of RBCs from 17 healthy individuals to PLY (118 ng/mL).  
 
FIGURE 2. Time dependence of the normalised contour radii for two cells from the same population 
exposed to PLY (59 ng/mL). The radii at each time point (Ri) are normalised with respect to the values 
before the addition of toxin (R0). Arrows indicate the onset of cell lysis. 
 
FIGURE 3. Human RBCs with prolonged resistance to eGFP-PLY show reduced toxin binding. (A) 
Representative DIC (top) and GFP fluorescence (bottom) images of RBCs incubated with eGFP-PLY 
(0.67 µg/mL). Lysed cells in the top image are characterised with faint outlines of their membranes. The 
cell with prolonged resistance to eGFP-PLY appears with a halo around its edge. Scale bar, 5 µm. (B) 
Correlation between GFP fluorescence intensity (hence eGFP-PLY concentration) on the surface of lysed 
and non-lysed cells. Each image had its background intensity subtracted and the GFP intensities of cells 
(n = 38) were measured 2 minutes after exposure to toxin using ImageJ software (53). Significant 
differences are indicated: P = 0.0028 (**), unpaired, two-tailed Student t test.  
 
FIGURE 4. Effect of cell morphology on the susceptibility of human RBCs to PLY. (A) RBCs from 17 
healthy individuals were incubated with PLY (118 ng/mL) and the percentage of lysed discocytes and 
stomatocytes in each population was determined after exposure to PLY for 15 minutes. Significant 
differences are indicated: P = 0.0211 (*), unpaired, two-tailed Mann-Whitney t test. (B) GFP fluorescence 
intensity of stomatocytes (n = 7) and discocytes (n = 7) after exposure to eGFP-6PLYL363A (1.12 µg/mL) 
for 2 min.  Each image had its background intensity subtracted and the GFP intensities of cells were 
measured using ImageJ software (53). Significant differences are indicated: P = 0.0012 (**), unpaired, 
two-tailed Mann-Whitney t test. (C) Merged DIC and GFP fluorescence images of echinocytes showing 
the distribution of eGFP-6PLYL363A on the surface of the cell. The fluorescence from eGFP-6PLYL363A 
is shown in red. Scale bar, 5 µm. 
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FIGURE 5. Haemolysis profiles of a population of human RBCs that has undergone different 
biochemical treatments: () control, () H2O2, () cumOOH, () DHEA, (⎔) calcium ionophore 
A23187. One representative experiment out of three is shown.  
 
FIGURE 6. Flow cytometry and phase contrast microscopy analysis of control and calcium ionophore 
A23187-treated human RBCs labelled with annexin V. (A) Dot plots of side-scattered (SSC-A) versus 
forward-scattered (FSC-A) light. One representative experiment out of three is shown. (B) Representative 
phase contrast microscopy images of control and calcium ionophore A23187-treated RBCs. Scale bar, 5 
µm. 
 
FIGURE 7. Flow cytometry analysis of annexin V-labelled control and calcium ionophore A23187-
treated RBCs before and after eGFP-6PLYL363A binding. Double fluorescence plots of red (Ex633 
nm/Em650-670 nm, annexin V) and green fluorescence (Ex488 nm/Em515-545 nm, eGFP-6PLY
L363A
) of (A) control 
- before toxin, (B) calcium ionophore A23187 - before toxin, (C) control - after toxin, (B) calcium 
ionophore A23187 - after toxin. Q1 = green, Q2 = green and red, Q3 = red, Q4 = not green and not red. 
 
FIGURE 8. Differences in the membrane physical properties of individual cells within a population of 
human RBCs are correlated with the susceptibility of cells to PLY. (A) Dependence of the red blood cell 
membrane bending elastic modulus on the time to lysis. Cells (n = 9) were exposed to 59 ng/mL PLY. 
One representative experiment out of three is shown. Linear regression line, R
2
 = 0.52, P = 0.027 (*). (B) 
Dependence of the RBC membrane dipole potential on the time to lysis. Cells (n = 25) were exposed to 
5.9 ng/mL PLY. One representative experiment out of three is shown. Linear regression line, R
2
 = 0.40, P 
= 0.002 (**). (C) Dependence of the measured fluorescence intensity of FPE-labelled RBCs on the time 
to lysis. Cells (n = 108) were exposed to 5.9 ng/mL PLY. One representative experiment out of three is 
shown. Linear regression line, R
2
 = 0.52, P = 0.029 (*). 
 
FIGURE 9. Correlation between levels of Hba1c and susceptibility of RBCs from individuals with 
diabetes to PLY. (A) Samples (n = 13) derived from subjects with diabetes not on metformin therapy: R
2 
= 
0.410, P = 0.018 (*). (B) Samples (n = 23) derived from subjects with diabetes on metformin therapy: R
2 
= 0.054, P = 0.285 (not significant). RBCs from individuals with diabetes were exposed to PLY (118 
ng/mL) and the percentage of live cells after exposure to toxin for 30 minutes was plotted against levels 
of Hba1c. 
 
FIGURE 10. RBCs from individuals with diabetes () show increased resistance to PLY (A) and PFO 
(B) relative to RBCs from healthy individuals (). Average (± SEM) time course of haemolysis induced 
by PLY (118 ng/mL) or PFO (72 ng/mL) in RBCs from healthy individuals (n = 17) and individuals with 
diabetes not on metformin therapy (n = 13). Cell lysis was monitored by phase contrast microscopy for 30 
minutes.  
 
FIGURE 11. Dependence of the measured projection length, L, on the applied pressure, P (L and P 
are scaled according to Equation (1)) for samples derived from subjects with diabetes () and from 
healthy controls (). Each point represents an average measurements for each group (n = 12 in the 
diabetic group and n = 14 in the healthy control group). The modulus of shear elasticity was evaluated 
from the gradient of the linear fits.     
 
FIGURE 12. Isosurface of PLY monomer. (A) Ribbon representation of the PLY peptide backbone with 
the four domains numbered. The highly conserved tryptophan-rich loop and the cholesterol binding 
region at the base of domain 4 are shown in stick and ball representations, respectively. The two putative 
sugar-binding sites, site 1 near the conserved tryptophan-rich loop (in purple) and site 2 at the domain 3-
domain 4 interface (grey), are shown in stick representation. (B) The corresponding PLY isosurface was 
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drawn at -1 (red) and +1 (blue) contour levels as calculated and drawn using the APBS (125,126) add-on 
to PyMol (127). The field projecting from the PLY monomer is mostly, but not completely, negative.  
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FIGURE 1 
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FIGURE 2 
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FIGURE 3 
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FIGURE 4 
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FIGURE 5 
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FIGURE 8 
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FIGURE 9 
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FIGURE 10 
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FIGURE 11 
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FIGURE 12 
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